 Catecholaminergic systems medulla oblongata parkinsonian syndromes quantitative immunohistochemical study Parkinson disease progressive supranuclear palsy striatonigral degeneration tyrosine-hydroxylase TH neurons medulla oblongata cell groups autopsy tissue patients Parkinson disease PD progressive supranuclear palsy PSP striatonigral degeneration SND controls estimated total number TH-positive neurons regions normal PD PSP patients sparing medullary catecholaminergic cells PD PSP minor degree melanization possibility intermediate compounds oxidative catabolism norepinephrine epinephrine cytotoxic degradation dopamine Patients SND marked loss TH-immunoreactive cells groups impairment vasomotor control characteristic disease